JP6444440B2 - アケビ抽出物の製造方法およびその抽出物を用いた機能性食品 - Google Patents
アケビ抽出物の製造方法およびその抽出物を用いた機能性食品 Download PDFInfo
- Publication number
- JP6444440B2 JP6444440B2 JP2017047559A JP2017047559A JP6444440B2 JP 6444440 B2 JP6444440 B2 JP 6444440B2 JP 2017047559 A JP2017047559 A JP 2017047559A JP 2017047559 A JP2017047559 A JP 2017047559A JP 6444440 B2 JP6444440 B2 JP 6444440B2
- Authority
- JP
- Japan
- Prior art keywords
- akebi
- extract
- seeds
- producing
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 240000008027 Akebia quinata Species 0.000 title claims description 128
- 235000007756 Akebia quinata Nutrition 0.000 title claims description 128
- 239000000284 extract Substances 0.000 title claims description 76
- 238000004519 manufacturing process Methods 0.000 title claims description 27
- 235000013376 functional food Nutrition 0.000 title description 9
- 229930182490 saponin Natural products 0.000 claims description 44
- 150000007949 saponins Chemical class 0.000 claims description 44
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 239000002994 raw material Substances 0.000 claims description 25
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 18
- 235000008397 ginger Nutrition 0.000 claims description 18
- 239000006228 supernatant Substances 0.000 claims description 13
- 230000032683 aging Effects 0.000 claims description 12
- 241000208340 Araliaceae Species 0.000 claims description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 10
- 235000008434 ginseng Nutrition 0.000 claims description 10
- 230000001678 irradiating effect Effects 0.000 claims description 10
- 239000000654 additive Substances 0.000 claims description 9
- 240000002234 Allium sativum Species 0.000 claims description 6
- 235000004611 garlic Nutrition 0.000 claims description 6
- 244000046146 Pueraria lobata Species 0.000 claims description 5
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 5
- 240000005717 Dioscorea alata Species 0.000 claims description 4
- 235000002723 Dioscorea alata Nutrition 0.000 claims description 4
- 235000007056 Dioscorea composita Nutrition 0.000 claims description 4
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 claims description 4
- 235000005362 Dioscorea floribunda Nutrition 0.000 claims description 4
- 235000004868 Dioscorea macrostachya Nutrition 0.000 claims description 4
- 235000005361 Dioscorea nummularia Nutrition 0.000 claims description 4
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 claims description 4
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 claims description 4
- 235000004879 dioscorea Nutrition 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 3
- 244000273928 Zingiber officinale Species 0.000 claims 2
- 241000252233 Cyprinus carpio Species 0.000 claims 1
- 238000000605 extraction Methods 0.000 description 49
- 235000017709 saponins Nutrition 0.000 description 43
- 241000234314 Zingiber Species 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 235000013399 edible fruits Nutrition 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000000843 powder Substances 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000005070 ripening Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 208000024798 heartburn Diseases 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- DLNAGMLXUYEHQS-UHFFFAOYSA-N 3-O-beta-D-glucopyranosylserjanic acid Natural products COC(=O)C1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(CO)C(O)C(O)C6O)C(C)(C)C5CCC34C)C2C1)C(=O)O DLNAGMLXUYEHQS-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 240000005109 Cryptomeria japonica Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000008881 Oenanthe javanica Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- SOLICHUQXFAOEP-YDIXZRNLSA-N Pulsatilla saponin D Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(CC[C@]6(CCC(C)(C)C[C@H]6C5=CC4)C(O)=O)C)(C)CC3)(C)CC2)(C)CO)OC[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H]1O SOLICHUQXFAOEP-YDIXZRNLSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 240000006831 Rubus chamaemorus Species 0.000 description 1
- 235000016554 Rubus chamaemorus Nutrition 0.000 description 1
- IFJUVMQPFHUIKX-UHFFFAOYSA-N Saponin D Natural products CC1CCC2(OC1)OC3CC4C5CCC6CC(CCC6(C)C5CC(=O)C4(C)C3C2C)OC7OC(CO)C(OC8OC(CO)C(OC9OC(CO)C(OC%10OC(C)C(O)C(O)C%10O)C(O)C9OC%11OC(O)C(O)CC%11O)C(O)C8O)C(O)C7O IFJUVMQPFHUIKX-UHFFFAOYSA-N 0.000 description 1
- FJESIUXDUUJRCG-UHFFFAOYSA-N Saponin D Chemical compound OC1C(O)C(O)C(C)OC1OC1C(OC2C(C3C(C4C(C56CC7(C(C(CC(O7)C=C(C)C)(C)OC7C(C(O)C(O)C(C)O7)O)C6CC4)OC5)(C)CC3)(C)CC2)(C)C)OC(CO)C(O)C1O FJESIUXDUUJRCG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000425037 Toona sinensis Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- TXUSTSJRABHHQP-UFGIQYKASA-N pulsatilla saponin D Natural products C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO[C@H]2O[C@H]3CC[C@@]4(C)[C@@H](CC[C@]5(C)[C@@H]4CC=C6[C@@H]7CC(C)(C)CC[C@@]7(CC[C@@]56C)C(=O)O)[C@]3(C)O)O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H](O)[C@H](O)[C@H]1O TXUSTSJRABHHQP-UFGIQYKASA-N 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/48—Ultrasonic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Fruits And Vegetables (AREA)
Description
a)アケビ種子およびアケビ果肉が含まれた原料を熟成するステップと、
b)アルコール抽出液を用いて熟成した前記原料からサポニンが有効成分として含有された抽出物を抽出するステップと、
を含むことができる。
b1)前記a)で熟成された原料にアルコール抽出液を添加して超音波を照射するステップと、
b2)前記b1)の生成物を遠心分離した後、上澄み液を回収して第1抽出物を製造するステップと、
を含むことができる。
a)アケビ種子およびアケビ果肉を含む原料を熟成するステップと、
b)アルコール抽出液を添加して熟成した前記原料からサポニンが有効成分として含有された抽出物を抽出するステップと、を含むことができる。
b1)前記a)の熟成された原料にアルコール抽出液を添加した後、超音波を照射するステップと、
b2)前記b1)ステップの生成物を遠心分離した後、上澄み液を回収して抽出物を製造するステップと、
を含んでもよく、b2)における上澄み液が除去された残渣を前記b1)の原料とし、アルコール抽出液を添加した後、b1)およびb2)ステップを1回または2回以上繰り返してもよい。好ましくは2回繰り返してもよい。
アケビ種子粉末1gにそれぞれアケビ果肉粉末0g(比較例1)、0.3g(実施例1‐1)、0.5g(実施例1‐2)、0.7g(実施例1‐3)、1.0g(実施例1‐4)、1.5g(実施例1‐5)、2.0g(実施例1‐6)を混合した後、精製水10mlに入れて45℃で5時間熟成する。これにエタノール80重量%、水20重量%の抽出液20mlを添加して攪拌しながら30kHzの超音波を30分間照射する。次に、3000rpmで20分間遠心分離を経て上澄み液を回収し、第1抽出物を製造する。前記上澄み液が除去された残渣に前記抽出液を30mlさらに添加して30分間攪拌しながら30kHzの超音波を照射して遠心分離後上澄み液を回収し、第2抽出物を製造する。前記第1抽出物と第2抽出物を合わせて減圧乾燥した後、精製水100mlに溶解して凍結乾燥する。次に、高速液体クロマトグラフィー(Waters、Waters2695 HPLC system)を用いてサポニンの含有量を測定し、表1に示した。
アケビ種子1g、アケビ果肉1gにショウガをそれぞれ0g(実施例2‐1)、0.03g(実施例2‐2)、0.05g(実施例2‐3)、0.1g(実施例2‐4)、0.15g(実施例2‐5)、0.2g(実施例2‐6)、0.3g(実施例2‐7)を混合し、実施例1のような方法で実験してサポニンの含有量を測定した後、表2に示した。
アケビ種子粉末5gとアケビ果肉粉末5gの混合物を精製水50mlに入れてそれぞれ20℃(実施例3‐1)、25℃(実施例3‐2)、30℃(実施例3‐3)、35℃(実施例3‐4)、40℃(実施例3‐5)、45℃(実施例3‐6)、50℃(実施例3‐7)、55℃(実施例3‐8)、60℃(実施例3‐9)で5時間熟成する。これにエタノール80重量%、水20重量%の抽出液70mlを添加して攪拌しながら30kHzの超音波を30分間照射する。次に、3000rpmで20分間遠心分離を経て上澄み液を回収し、第1抽出物を製造する。前記上澄み液が除去された残渣に前記抽出液を100mlさらに添加して30分間攪拌しながら30kHzの超音波を照射して遠心分離した後、上澄み液を回収し、第2抽出物を製造する。前記第1抽出物と第2抽出物を合わせて減圧乾燥した後、精製水400mlに溶解して凍結乾燥する。次に、高速液体クロマトグラフィーを使用してサポニンの含有量を測定した。
熟成温度を40℃とし、実施例3のような方法で抽出を行う際、第1抽出物の製造過程および第2抽出物の製造過程における超音波の照射時間をそれぞれ0分(実施例4‐1)、10分(実施例4‐2)、20分(実施例4‐3)、30分(実施例4‐4)、40分(実施例4‐5)、50分(実施例4‐6)、60分(実施例4‐7)、70分(実施例4‐8)として抽出を行った。各実施例別のサポニンの含有量を表4に示した。
前記抽出物の製造方法により比較例1、実施例1‐4、実施例2‐4で得られた抽出物、および実施例2‐4で得られた抽出物に乾燥したチョウセンニンジン粉末0.5gをさらに混合した抽出物(実施例5)を製造し、20〜40代の訓練された評価員50名にそれぞれ100mgずつ服用させた。服用後にそれぞれ感じる香と味の特性に対して、5点スケール(1点:非常に嫌いまたは非常に強い、2点:嫌い、3点:普通、4点:満足または良い、5点:非常に満足または非常に良い)で表示させた後、その平均値を求め、表5に示した。
前記実施例2‐4による抽出物を男女各15名ずつ総30名の20〜50代の一般人に毎日一日二回100mgずつ10日間服用させ、活力増進効果を比較するために疲労回復度を5点スケール(5点:非常に優秀、4点:優秀、3点:差異なし、2点:悪い、1点:非常に悪い)で表示させ、平均値を求めた結果、平均が4、標準偏差は0.73と現れ、疲労回復効果を有することが分かる。
前記実施例2‐4による抽出物10mgを毎日服用する実験群、小麦粉で製造したプラセボ10mgを毎日服用する対照群を定め、1年間実験を行った。実験群と対照群の1年間の風邪の発病回数と風邪の継続日を表示し、表6に示した。ここで、風邪とは、微熱または高熱、咽頭痛、咳、筋肉痛、悪寒などの症状が2以上現れる状態と定義した。
前記実施例2‐4による抽出物を胸焼け、呑酸など胃部の不快感を訴える10名の一般人を対象として一日2回0.1gずつ一ヶ月服用させた後、胸焼け、悪心および胃液逆流症状の改善度を5点スケール(1:非常に悪化、2:悪化、3:変化なし、4:改善する、5:非常に改善する)で表示させた。その結果、胸焼けの場合、平均4.4点、標準偏差0.69を示しており、悪心および胃液逆流は、平均4.0点、標準偏差0.94と示された。
実施例2‐4による抽出物150mg、結晶性セルロース50mg、乳糖50mg、ステアリン酸マグネシウム3mgおよびエタノールを混合して顆粒を製造する。
実施例2‐4による抽出物200mg、タルク10mg、コロイドシリカ5mg、乳糖85mgを通常のカプセル剤の製造方法で製造する。
実施例2‐4による抽出物4g、オリゴ糖0.5g、高フルクトースコーンシロップ1g、クエン酸0.1g、ビタミンC0.2gおよび精製水50mlを混合し、通常の飲料製造方法で製造する。
Claims (8)
- a)アケビ種子、アケビ果肉およびショウガを含む原料を熟成するステップと、
b)アルコール抽出液を用いて熟成した前記原料からサポニンが有効成分として含有された抽出物を抽出するステップと、を含む、アケビ抽出物の製造方法。 - 前記原料は、アケビ種子1重量部に対してアケビ果肉を0.5〜5重量部含むことを特徴とする、請求項1に記載のアケビ抽出物の製造方法。
- 前記熟成するステップにおいて、温度は20〜60℃であることを特徴とする、請求項1又は2に記載のアケビ抽出物の製造方法。
- 前記原料は、アケビ種子1重量部に対してショウガを0.05〜0.2重量部含むことを特徴とする、請求項1に記載のアケビ抽出物の製造方法。
- 前記原料は、アケビ種子1重量部に対してチョウセンニンジン、野生のチョウセンニンジン、キキョウ、ツルニンジン、クズおよびヤマノイモからなる群から選択される1または2以上の添加物を0.1〜1重量部さらに含むことを特徴とする、請求項1に記載のアケビ抽出物の製造方法。
- 前記b)ステップは、
b1)前記a)ステップの熟成された原料にアルコール抽出液を添加した後、超音波を照射するステップと、
b2)前記b1)の生成物を遠心分離した後、上澄み液を回収して抽出物を製造するステップと、を含むことを特徴とする、請求項1に記載のアケビ抽出物の製造方法。 - 前記b2)で上澄み液が除去された残渣を前記a)ステップの原料とし、前記b1)およびb2)ステップを2回以上繰り返すことを特徴とする、請求項6に記載のアケビ抽出物の製造方法。
- 前記b1)において超音波の照射は20〜60分である、請求項6に記載のアケビ抽出物の製造方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160044924A KR101671961B1 (ko) | 2016-04-12 | 2016-04-12 | 으름 추출물의 제조 방법 및 이 추출물을 이용한 기능성 식품 |
KR10-2016-0044924 | 2016-04-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017189160A JP2017189160A (ja) | 2017-10-19 |
JP6444440B2 true JP6444440B2 (ja) | 2018-12-26 |
Family
ID=57571275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017047559A Expired - Fee Related JP6444440B2 (ja) | 2016-04-12 | 2017-03-13 | アケビ抽出物の製造方法およびその抽出物を用いた機能性食品 |
Country Status (4)
Country | Link |
---|---|
US (1) | US10463706B2 (ja) |
JP (1) | JP6444440B2 (ja) |
KR (1) | KR101671961B1 (ja) |
CN (1) | CN107280002A (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102036826B1 (ko) * | 2017-06-29 | 2019-10-25 | 주식회사두웰바이오 | 으름 추출물 또는 이의 분획물을 유효성분으로 함유하는 아토피성 피부염 예방 또는 치료용 조성물 |
KR102062773B1 (ko) | 2018-08-03 | 2020-01-06 | 건국대학교 글로컬산학협력단 | 오르모사닌을 유효성분으로 하는 알코올성 간질환의 치료 또는 예방용 조성물 |
KR102643565B1 (ko) * | 2023-09-25 | 2024-03-05 | 박성화 | 개선된 식감의 닭칼국수 및 이의 제조 방법 |
KR102700396B1 (ko) * | 2024-03-29 | 2024-08-29 | 농업회사법인 주식회사 새벽애 | 기능성 두부 제조방법 및 그에 의해 제조된 기능성 두부 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1178116A (zh) * | 1997-07-12 | 1998-04-08 | 迟经惠 | 女子补阴丸 |
CN1173715C (zh) * | 2000-03-20 | 2004-11-03 | 范永昌 | 一种治疗和预防病理性衰老的药丸 |
KR20040072135A (ko) * | 2003-02-10 | 2004-08-18 | 김송배 | 진통제 조성물 |
KR100573375B1 (ko) * | 2004-02-27 | 2006-04-25 | 김숭진 | 으름덩굴 종자 추출물을 포함하는 항암 조성물 및 그의제조방법 |
KR100628334B1 (ko) * | 2004-07-30 | 2006-09-27 | 김송배 | 백두옹의 항암효과를 증진시키는 방법 및 이 방법으로제조된 항암 조성물 |
KR100826902B1 (ko) * | 2006-01-04 | 2008-05-06 | 박미숙 | 기능성 한방 발효액 제조 방법 |
KR101483440B1 (ko) * | 2008-05-02 | 2015-01-19 | (주)아모레퍼시픽 | 포제를 활용한 약용식물 추출물 및 이를 함유하는 피부외용제 조성물 |
JP5500821B2 (ja) * | 2008-12-25 | 2014-05-21 | ハウス食品グループ本社株式会社 | 苦味を抑制したサポニン |
CN101590086B (zh) * | 2009-06-23 | 2011-10-12 | 徐江平 | 一种预知子提取物及其制剂与用途 |
JP2012016310A (ja) * | 2010-07-08 | 2012-01-26 | Tohoku Engineering Kk | 乾燥果実の製造方法及び乾燥果実 |
JP2014034552A (ja) * | 2012-08-09 | 2014-02-24 | Kao Corp | バイオフィルム形成抑制剤 |
JP2014152147A (ja) * | 2013-02-12 | 2014-08-25 | Snowden Co Ltd | ピロリ菌除菌療法補助剤ならびにこれを用いた医薬品組成物及び飲食品組成物 |
JP6247847B2 (ja) * | 2013-07-10 | 2017-12-13 | 日本メナード化粧品株式会社 | 皮膚のしわ形成防止・改善剤、ヒアルロン酸生成促進剤、コラーゲン生成促進剤及びmmp阻害剤 |
JP2014111652A (ja) * | 2014-02-28 | 2014-06-19 | Lotte Co Ltd | メチオニナーゼ阻害剤及びそれを含有する口腔用組成物並びに飲食品 |
-
2016
- 2016-04-12 KR KR1020160044924A patent/KR101671961B1/ko active Active
-
2017
- 2017-02-22 CN CN201710096325.8A patent/CN107280002A/zh active Pending
- 2017-03-13 JP JP2017047559A patent/JP6444440B2/ja not_active Expired - Fee Related
- 2017-03-21 US US15/464,799 patent/US10463706B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US10463706B2 (en) | 2019-11-05 |
JP2017189160A (ja) | 2017-10-19 |
US20170290868A1 (en) | 2017-10-12 |
CN107280002A (zh) | 2017-10-24 |
KR101671961B1 (ko) | 2016-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shastri et al. | Actinidia deliciosa: A review | |
KR100935847B1 (ko) | 홍삼 절편의 제조 방법 | |
JP6444440B2 (ja) | アケビ抽出物の製造方法およびその抽出物を用いた機能性食品 | |
JP6404339B2 (ja) | 月経前症候群及び月経痛緩和の機能を持つ組成物 | |
KR101817055B1 (ko) | 항산화 및 면역기능 증진 활성을 갖는 덖음차 조성물 | |
KR101316091B1 (ko) | 황칠나무를 이용한 건강보조식품 및 이의 제조방법 | |
KR20150040392A (ko) | 스테비아 음료원액제조방법 | |
KR101686196B1 (ko) | 진세노사이드가 증진된 홍삼의 제조방법 및 이에 의한 홍삼슬라이스 | |
KR20170061327A (ko) | 나무딸기 잎 및 줄기 추출물을 주성분으로 하는 항비만 조성물 및 그 제조방법 | |
KR100894636B1 (ko) | 둥근마추출액을 함유한 음료의 제조방법 | |
KR101525877B1 (ko) | 피부 주름 개선 및 피부 노화 방지를 위한 조성물 | |
KR102523536B1 (ko) | 껍질을 포함하는 과일청 및 그 제조방법 | |
JP2005237291A (ja) | 健康食品 | |
KR102428520B1 (ko) | 홍삼농축액, 당귀추출물, 클로렐라 및 소엽추출물을 이용한 리큐르주의 제조방법 | |
KR102404644B1 (ko) | 숙취해소용 조성물 및 이를 포함하는 건강에 좋은 식품 | |
KR100953958B1 (ko) | 면류의 제조방법 | |
KR100642801B1 (ko) | 한약재와 배 추출물을 배합한 항당뇨 식품 조성물 및 그의제조방법 | |
KR101846744B1 (ko) | 항산화 효과가 있는 반건조 고구마 및 이의 제조방법 | |
CN104256257A (zh) | 具有调节脂蛋白胆固醇组成比例作用的组合物及其应用 | |
KR20200081550A (ko) | 굼벵이 엑기스 발효물을 포함하는 기능성 식품 조성물 및 이의 제조 방법 | |
KR102428525B1 (ko) | 은행잎추출물, 홍삼농축액 및 해안소나무껍질추출물을 이용한 리큐르주의 제조방법 | |
KR20190099786A (ko) | 배즙에 오가피를 넣은 제조방법 | |
KR102489041B1 (ko) | 기능성 양념을 사용한 저염 배추 김치의 제조방법 | |
KR102450640B1 (ko) | 기능성 원료를 첨가한 비트 주스의 제조 방법 | |
KR102492573B1 (ko) | 우동 소스 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180320 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180618 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20181112 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181127 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6444440 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |